Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart valve delivery system recalled | Surgeon makes history | Head-to-head TTVR study now underway | TAVR & SAVR outcomes
Wednesday, July 15, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

Medtronic recalls heart valve delivery system due to safety risk

The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.

READ MORE >
Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls heart valve delivery system due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]
The same device was previously recalled back in 2022. Customers are urged to return any unused delivery systems included in the recall to Medtronic.
READ MORE >

Heart surgeon makes history, performs first robotic procedure of its kind

A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.

READ MORE >
Rakesh M. Suri, MD, DPhil, Corewell Health William Beaumont University Hospital
Share on Twitter Share on Facebook Share on Linkedin

Heart surgeon makes history, performs first robotic procedure of its kind

Share on Twitter Share on Facebook Share on Linkedin
Rakesh M. Suri, MD, DPhil, Corewell Health William Beaumont University Hospital
A surgeon in Michigan has performed the world’s first single-port robotic mitral valve repair.
READ MORE >

Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.
READ MORE >

ACC takes on DOAC use with new scientific statement

Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.

READ MORE >
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Share on Twitter Share on Facebook Share on Linkedin

ACC takes on DOAC use with new scientific statement

Share on Twitter Share on Facebook Share on Linkedin
Rivaroxaban (Xarelto) is among the direct oral anticoagulants (DOACs) including in the new 2026 ACC consensus statement on the use of DOACs.
Direct oral anticoagulants continue to be underutilized and inappropriately dosed. The American College of Cardiology hopes a new scientific statement can help address those issues and provide clinicians with an updated look at this important topic.
READ MORE >

AI company founded by cardiologist gains FDA clearance, raises $8.5M

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

AI company founded by cardiologist gains FDA clearance, raises $8.5M

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.
READ MORE >

Topaz vs. Evoque: New head-to-head study for TTVR devices now underway

Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 

READ MORE >
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Topaz vs. Evoque: New head-to-head study for TTVR devices now underway

Share on Twitter Share on Facebook Share on Linkedin
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 
READ MORE >

Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis

TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.

READ MORE >
heart doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis

Share on Twitter Share on Facebook Share on Linkedin
heart doctor cardiologist
TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.
READ MORE >

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup